New heart valve under 10-Year watch: hope for aortic stenosis patients
NCT ID NCT06953206
First seen Apr 01, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study will follow 500 adults with severe aortic stenosis who receive a new type of heart valve (SAPIEN 3 Ultra Resilia) through a minimally invasive procedure. Researchers will track how well the valve works and how safe it is over 10 years. The goal is to understand the valve's long-term performance, not to cure the underlying disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heart and Diabetes Center North Rhine-Westphalia
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Conditions
Explore the condition pages connected to this study.